GAUDIUMIVF vs KPL: Stock Comparison

Gaudium IVF and Women Health Ltd vs Kwality Pharmaceuticals Ltd

Live data: 27 April 2026, 4:01 PM IST • Source: NSE and company filings

Kwality Pharmaceuticals Ltd is the larger company by market capitalisation. Gaudium IVF and Women Health Ltd shows lower leverage, a higher ROCE and a higher net margin, while Kwality Pharmaceuticals Ltd shows a lower P/E and a higher ROE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Gaudium IVF and Women Health Ltd and Kwality Pharmaceuticals Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, GAUDIUMIVF is more favourable on 6 of 13 scored metrics and KPL on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
KPL is the larger company
₹2,692 Cr vs ₹1,059 Cr
P/E Ratio
KPL has a lower P/E
39.83x vs 43.3x
P/B Ratio
GAUDIUMIVF has a lower P/B
6.96x vs 8.09x
EPS
KPL has higher earnings per share
₹64.9 vs ₹3.12
Qtr Sales Growth
GAUDIUMIVF has stronger quarterly sales growth
56.2% vs 35.8%
Qtr Profit Growth
KPL has stronger quarterly profit growth
74.6% vs 53.7%
ROE
KPL has a higher ROE
22.8% vs 16.08%
ROCE
GAUDIUMIVF has a higher ROCE
48.6% vs 24.2%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricGAUDIUMIVFKPL
Live Price₹128.17₹2,590.4
Day Change3.04%-4.34%
Volume11.51 L26,342
52-Week High₹133₹2,890.3
52-Week Low₹69.18₹1,561
Distance from 52W High-3.63%-10.38%

Valuation

MetricGAUDIUMIVFKPL
Market Cap₹1,059 Cr₹2,692 Cr
P/E Ratio43.3x39.83x
P/B Ratio6.96x8.09x
EPS₹3.12₹64.9
Book Value₹0₹320
Dividend Yield0%0%

Growth

MetricGAUDIUMIVFKPL
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth56.2%35.8%
Qtr Profit Growth53.7%74.6%

Profitability & Leverage

MetricGAUDIUMIVFKPL
ROE16.08%22.8%
ROCE48.6%24.2%
Net Margin23.47%13.39%
Operating Margin34.2%23.5%
Debt to Equity0.15x0.39x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGAUDIUMIVFKPL
Promoter Holding71.29%54.87% 0.04 pp
FII Holding3.02% 3.68 pp2.79% 2.29 pp
DII Holding2.22% 0.4 pp0.36% 0.03 pp
Public Holding23.47% 4.08 pp41.98% 2.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Gaudium IVF and Women Health Ltd and Kwality Pharmaceuticals Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.